| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| review article | Q7318358 |
| P356 | DOI | 10.1345/APH.1P429 |
| P698 | PubMed publication ID | 21205952 |
| P50 | author | Maria Rubio-Valera | Q43088190 |
| Antoni Serrano-Blanco | Q43088197 | ||
| Javier García-Campayo | Q46697266 | ||
| P2093 | author name string | Ana Fernández | |
| Jesús Magdalena-Belío | |||
| Marian March Pujol | |||
| Yolanda López del Hoyo | |||
| P2860 | cites work | Projections of global mortality and burden of disease from 2002 to 2030 | Q21144688 |
| Prevalence, Severity, and Unmet Need for Treatment of Mental Disorders in the World Health Organization World Mental Health Surveys | Q22252996 | ||
| CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials | Q24614627 | ||
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860537 | ||
| Assessing the quality of reports of randomized clinical trials: is blinding necessary? | Q27860973 | ||
| Prophylactic respiratory physiotherapy after cardiac surgery: systematic review | Q33195891 | ||
| Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes | Q33264773 | ||
| Ketamine and postoperative pain--a quantitative systematic review of randomised trials | Q34380047 | ||
| Risk factors and predictors of compliance in depression | Q35556158 | ||
| Evaluating the impact of pharmacists in mental health: a systematic review | Q35616184 | ||
| Collaborative care for depression in primary care. Making sense of a complex intervention: systematic review and meta-regression | Q36670374 | ||
| Systematic review of multifaceted interventions to improve depression care. | Q36750854 | ||
| Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management | Q36915765 | ||
| Sensitivity of patient outcomes to pharmacist interventions. Part II: Systematic review and meta-analysis in hypertension management | Q36966475 | ||
| Pharmacist care of patients with heart failure: a systematic review of randomized trials | Q37138834 | ||
| Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management | Q37235854 | ||
| Pharmacist telemonitoring of antidepressant use: effects on pharmacist-patient collaboration | Q40409075 | ||
| Description of a clinical pharmacist intervention administered to primary care patients with depression | Q40513321 | ||
| Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial | Q40558461 | ||
| Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers | Q45334438 | ||
| Patient outcomes following an intervention involving community pharmacists in the management of depression. | Q51775849 | ||
| Pharmacotherapy of mood disorders and treatment discontinuation. | Q52291594 | ||
| The impact of a pharmacist intervention on 6-month outcomes in depressed primary care patients | Q58723304 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meta-analysis | Q815382 |
| systematic review | Q1504425 | ||
| P304 | page(s) | 39-48 | |
| P577 | publication date | 2011-01-04 | |
| P1433 | published in | Annals of Pharmacotherapy | Q4767858 |
| P1476 | title | Effectiveness of pharmacist care in the improvement of adherence to antidepressants: a systematic review and meta-analysis | |
| P478 | volume | 45 |
| Q38168741 | A comprehensive review of the impact of clinical pharmacy services on patient outcomes in mental health |
| Q39664010 | A survey of psychiatrists' expectations of clinical pharmacists in Riyadh, Saudi Arabia |
| Q35580286 | Adherence counseling during patient contacts in swiss community pharmacies |
| Q41894282 | Adherence to antidepressant medications: an evaluation of community pharmacists' counseling practices |
| Q59126207 | Anticholinergic discontinuation and cognitive functions in patients with schizophrenia: a pharmacist–physician collaboration in the outpatient department |
| Q38820952 | Common Factors in Pediatric Psychiatry: A Review of Essential and Adjunctive Mechanisms of Treatment Outcome |
| Q34947318 | Cost-effectiveness of a community pharmacist intervention in patients with depression: a randomized controlled trial (PRODEFAR Study). |
| Q92383362 | Creation and validation of a semi-quantitative instrument to assess the confidence of pharmacists in medication consultation for patients with depression: The pharmacists' confidence scale about medication consultation for depressive patients (PCMCD |
| Q28550045 | Effect of a Multi-Dimensional and Inter-Sectoral Intervention on the Adherence of Psychiatric Patients |
| Q37215008 | Effects of Telephone Counseling Intervention by Pharmacists (TelCIP) on Medication Adherence; Results of a Cluster Randomized Trial. |
| Q47851096 | Evaluating the Impact of an Anti-stigma Intervention on Pharmacy Students' Willingness to Counsel People Living with Mental Illness |
| Q64076931 | Evaluation of the Effectiveness of Clinical Pharmacists' Consultation in the Treatment of Infectious Diseases: A Single-Arm, Prospective Cohort Study |
| Q35853043 | Exploring an increased role for Australian community pharmacy in mental health professional service delivery: evaluation of the literature. |
| Q34329474 | Factors affecting collaboration between general practitioners and community pharmacists: a qualitative study. |
| Q44237975 | Factors associated with attitudes toward suicide: among Japanese pharmacists participating in the Board Certified Psychiatric Pharmacy Specialist Seminar |
| Q50436405 | Impact of pharmaceutical intervention in preventing relapses in depression in Primary Care |
| Q36195544 | Improving Patient's Primary Medication Adherence: The Value of Pharmaceutical Counseling |
| Q26771802 | Mapping the terrain: A conceptual schema for a mental health medication support service in community pharmacy |
| Q45074704 | Mental health treatment associated with community-based depression screening: considerations for planning multidisciplinary collaborative care |
| Q90608981 | Monitoring and managing medication adherence in community pharmacies in Quebec, Canada |
| Q34412191 | New roles for pharmacists in community mental health care: a narrative review |
| Q43849646 | Non-adherence to antibiotic therapy in patients visiting community pharmacies |
| Q97520149 | Pharmacists' roles in supporting people living with severe and persistent mental illness: a systematic review protocol |
| Q42011793 | Risk factors for drug nonadherence in antidepressant-treated patients and implications of pharmacist adherence instructions for adherence improvement |
| Q34132415 | The economics of medicines optimization: policy developments, remaining challenges and research priorities. |
| Q47677736 | The impact of a person-centred community pharmacy mental health medication support service on consumer outcomes |
| Q47566366 | The role of community pharmacists in the identification and ongoing management of women at risk for perinatal depression: A qualitative study |
| Q37190932 | Women and men report different behaviours in, and reasons for medication non-adherence: a nationwide Swedish survey |
Search more.